Fund HoldingsMerck & Co., Inc.

Total Portfolio Value
$349.44M
Total Bought
$35.60M
Total Sold
$949.9K
Net Transaction
+$34.65M
Filing Period:
Securities
SharesValue ($K)
Q4 2025
Q1 2026
Change
Q4 2025
Q1 2026
Weight (%)
Change
MODERNA INC(MRNA)2,308,1902,308,190068,069117,25633.56%+49,188
EIKON THERAPEUTICS INC01,666,666+1,666,666017,6335.05%+17,633
AKTIS ONCOLOGY INC(AKTS)0952,844+952,844017,0464.88%+17,046
KYMERA THERAPEUTICS INC(KYMR)772,165772,165060,08264,31418.40%+4,231
ENTRADA THERAPEUTICS INC1,739,7681,739,768017,88521,9566.28%+4,071
SUTRO BIOPHARMA INC272,351272,35103,1516,7841.94%+3,633
ALECTOR INC3,545,7193,545,71905,5317,6232.18%+2,092
XILIO THERAPEUTICS INC0105,982+105,98208910.26%+891
TUHURA BIOSCIENCES13,95019,445+5,49511350.01%+24
NEUPHORIA THERAPEUTICS INC10,02710,027039410.01%+2
CARISMA THERAPEUTICS INC1,473,2401,473,240063480.01%-15
XILIO THERAPEUTICS INC1,483,7580-1,483,7589500-950
VIRIDIAN THERAPEUTICS INC(VRDN)93,41493,41402,9071,8270.52%-1,080
EVAXION BIOTECH A/S1,214,1261,214,12605,7914,5171.29%-1,275
PERSONALIS INC(PSNL)14,044,94314,044,9430111,79889,46625.60%-22,331
Page 1 of 1